This coenzyme is vital for cellular energy production and has been shown to help improve overall energy levels, especially for those who experience fatigue due to aging or chronic conditions
Reduced (Active) L-Glutathione: We use the reduced form the biologically active form your body can utilise directly, unlike oxidised glutathione (GSSG) which must be converted first
After decades with no disease-modifying drug, 20242026 finally delivered the first targeted therapies: Novartis ianalumab met both NEPTUNUS-1 & NEPTUNUS-2 Phase 3 endpoints and won FDA Breakthrough Therapy status in Jan 2026, and J&Js nipocalimab was positive in the Phase 2 DAHLIAS trial ( The Lancet )
For peptides with low sublingual bioavailability, the amount of product needed to achieve therapeutic blood levels may exceed what can practically be administered sublingually in a single dose
For storage, keeping peptides in dark conditions, either in opaque containers or covered storage areas, provides additional protection
